Identification and evaluation of 55 genetic variations in the BRCA1 and the BRCA2 genes of patients from 50 Japanese breast cancer families

Journal of Human Genetics

Volumn 49, Issue 7, 2004, Pages 391-395

  Kawahara, Masanori ^a,b   Sakayori, Masato ^a   Shiraishi, Kazuko ^a,c   Nomizu, Tadashi ^d   Takeda, Motohiro ^c   Abe, Rikiya ^e   Ohuchi, Noriaki ^c   Takenoshita, Seiichi ^b   Ishioka, Chikashi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b Fukushima Pref College of Medicine   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d HOSHI GENERAL HOSPITAL   (Japan)

^e Tohoku Familial Tumor Association   (Japan)

Author keywords

BRCA1; BRCA2; Breast cancer susceptibility gene; Direct DNA sequencing; Japanese population; Single nucleotide polymorphism (SNP)

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BRCA2 GENE; BREAST CANCER; CANCER PATIENT; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA FLANKING REGION; DNA SEQUENCE; EVALUATION; FEMALE; GENE IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; ONCOGENE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 3843065378     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-004-0160-5     Document Type: Article

References (16)

1. Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83:1301-1308
2. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62:676-689
3. Ikeda N, Miyoshi Y, Yoneda K, Shiba E, Sekihara Y, Kinoshita M, Noguchi S (2001) Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 91:83-88
4. Inoue R, Fukutomi T, Ushijima T, Matsumoto Y, Sugimura T, Nagao M (1995) Germline mutation of BRCA1 in Japanese breast cancer families. Cancer Res 55:3521-3524
5. Inoue R, Ushijima T, Fukutomi T, Fukami A, Sugimura H, Inoue S, Okonogi H, Sugimura T, Matsumoto Y, Nagao M (1997) BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 74:199-204
6. Ishioka C, Suzuki T, FitzGerald M, Krainer M, Shimodaira H, Shimada A, Nomizu T, Isselbacher KJ, Haber D, Kanamaru R (1997) Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeast. Proc Natl Acad Sci USA 94:2449-2453
7. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W and others (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
8. Narod SA, Ford D, Devilee P, Barkardottir RB, Lynch HT, Smith SA, Ponder BA, Weber BL, Garber JE, Birch JM and others (1995) An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast cancer linkage consortium. Am J Hum Genet 56:254-264
9. Neuhausen SL (1999) Ethnic differences in cancer risk resulting from genetic variation. Cancer 86:2575-2582
10. Rebbeck TR (1999) Inherited genetic predisposition in breast cancer. A population-based perspective. Cancer 86:2493-2501
11. Sakayori M, Kawahara M, Shiraishi K, Nomizu T, Shimada A, Kudo T, Abe R, Ohuchi N, Takenoshita S, Kanamaru R, Ishioka C (2003) Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1 and BRCA2 genes in familial breast cancer. J Hum Genet 48:130-137
12. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401-1408
13. Takano M, Aida H, Tsuneki I, Takakuwa K, Hasegawa I, Tanaka H, Saito M, Tsuji S, Sonoda T, Hatae M, Chen JT, Takahashi K, Hasegawa K, Toyoda N, Saito N, Yakushiji M, Araki T, Tanaka K (1997) Mutational analysis of BRCA1 gene in ovarian and breast-ovarian cancer families in Japan. Jpn J Cancer Res 88:407-413
14. Tavtigian SV, Simard J, Rommens J. Couch F, Shattuck-Eidens D. Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF, Goldgar DE et al. (1996) The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12:333-337
15. Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Wacholder S, Tulinius H, Eyfjord JE (1998) Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 352:1337-1339
16. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792